$NWBO
NORTHWEST BIOTHERAPEUTICS INC

2014 Q2 Form 10-Q Financial Statement

#000114420414050484 Filed on August 15, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q4 2013 Q2
Revenue $0.00 $0.00 $272.0K
YoY Change -100.0% -100.0% -17.58%
Cost Of Revenue $0.00
YoY Change
Gross Profit $272.0K
YoY Change -17.58%
Gross Profit Margin 100.0%
Selling, General & Admin $3.880M $3.550M $3.290M
YoY Change 17.93% -52.79% 62.07%
% of Gross Profit 1209.56%
Research & Development $21.55M $11.12M $8.383M
YoY Change 157.06% 32.7% 19.08%
% of Gross Profit 3081.99%
Depreciation & Amortization $10.00K $0.00 $10.00K
YoY Change 0.0%
% of Gross Profit 3.68%
Operating Expenses $21.55M $14.67M $8.383M
YoY Change 157.06% -7.74% 19.08%
Operating Profit -$25.43M -$11.40M
YoY Change 122.97% 30.53%
Interest Expense $33.00K $930.0K $190.0K
YoY Change -82.63% -115.92% -88.22%
% of Operating Profit
Other Income/Expense, Net -$438.0K -$3.150M $0.00
YoY Change -65.38%
Pretax Income -$25.87M -$16.89M -$11.59M
YoY Change 123.21% -44.66% 14.19%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$25.87M -$16.89M -$11.59M
YoY Change 123.09% -44.66% 14.23%
Net Earnings / Revenue -4262.5%
Basic Earnings Per Share
Diluted Earnings Per Share -$450.4K -$426.0K -$398.1K
COMMON SHARES
Basic Shares Outstanding 57.20M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q2 2013 Q4 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.850M $18.50M $1.990M
YoY Change 344.72% 151.7% 362.79%
Cash & Equivalents $8.853M $18.50M $1.985M
Short-Term Investments
Other Short-Term Assets $3.590M $150.0K $360.0K
YoY Change 897.22% 36.36% 38.46%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $12.44M $18.65M $2.348M
YoY Change 429.98% 150.01% 163.82%
LONG-TERM ASSETS
Property, Plant & Equipment $77.00K $83.00K $89.00K
YoY Change -13.48% -12.63% -11.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $55.00K $55.00K $0.00
YoY Change 175.0% -100.0%
Total Long-Term Assets $132.0K $138.0K $89.00K
YoY Change 48.31% 23.21% -31.54%
TOTAL ASSETS
Total Short-Term Assets $12.44M $18.65M $2.348M
Total Long-Term Assets $132.0K $138.0K $89.00K
Total Assets $12.58M $18.78M $2.437M
YoY Change 416.04% 148.14% 138.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.543M $8.937M $15.31M
YoY Change -37.66% 9.45% 121.87%
Accrued Expenses $655.0K $842.0K $1.088M
YoY Change -39.8% 42.95% -75.5%
Deferred Revenue
YoY Change
Short-Term Debt $930.0K $930.0K $930.0K
YoY Change 0.0% 0.0%
Long-Term Debt Due $240.0K $290.0K $1.340M
YoY Change -82.09% -72.64% -92.93%
Total Short-Term Liabilities $42.45M $19.69M $18.67M
YoY Change 127.31% 83.26% -38.43%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $42.45M $19.69M $18.67M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $42.45M $19.69M $18.67M
YoY Change 127.32% 55.94% -41.05%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $427.2M $375.3M $318.0M
YoY Change 34.34% 23.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$29.87M -$9.818M -$27.25M
YoY Change
Total Liabilities & Shareholders Equity $12.58M $18.78M $2.437M
YoY Change 416.04% 148.14% 138.92%

Cashflow Statement

Concept 2014 Q2 2013 Q4 2013 Q2
OPERATING ACTIVITIES
Net Income -$25.87M -$16.89M -$11.59M
YoY Change 123.09% -44.66% 14.23%
Depreciation, Depletion And Amortization $10.00K $0.00 $10.00K
YoY Change 0.0%
Cash From Operating Activities -$16.94M -$14.60M -$8.210M
YoY Change 106.33% 77.18% 69.98%
INVESTING ACTIVITIES
Capital Expenditures $50.00K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$3.410M $4.500M $0.00
YoY Change
Cash From Investing Activities -$3.410M $4.550M $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 16.98M 25.69M 9.820M
YoY Change 72.91% 65.85% 86.69%
NET CHANGE
Cash From Operating Activities -16.94M -14.60M -8.210M
Cash From Investing Activities -3.410M 4.550M 0.000
Cash From Financing Activities 16.98M 25.69M 9.820M
Net Change In Cash -3.370M 15.64M 1.610M
YoY Change -309.32% 115.72% 302.5%
FREE CASH FLOW
Cash From Operating Activities -$16.94M -$14.60M -$8.210M
Capital Expenditures $50.00K $0.00
Free Cash Flow -$14.65M -$8.210M
YoY Change 77.79% 71.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
655000 USD
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
59000 USD
CY2014Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
427177000 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
-29872000 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12576000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8853000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18499000 USD
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
177000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
147000 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
12444000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
18646000 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
77000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
83000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19689000 USD
CY2013Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
8688000 USD
CY2014Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
22640 shares
CY2014Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
25581 shares
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8937000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
842000 USD
CY2013Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
288000 USD
CY2013Q4 us-gaap Notes Payable Current
NotesPayableCurrent
934000 USD
CY2013Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
8913000 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
46000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
375213000 USD
CY2013Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
384887000 USD
CY2013Q4 us-gaap Assets
Assets
18784000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-190000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-9818000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18784000 USD
CY2014Q2 us-gaap Assets
Assets
12576000 USD
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
9543000 USD
CY2014Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
238000 USD
CY2014Q2 us-gaap Notes Payable Current
NotesPayableCurrent
934000 USD
CY2014Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
31078000 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
42448000 USD
CY2014Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2014Q2 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
456793000 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-190000 USD
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
55000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
55000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Use of Estimates</font></font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 27.5pt; MARGIN: 0in 0in 0pt" align="justify"><i><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">In preparing financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates. On an ongoing basis, the Company evaluates its estimates and assumptions. These estimates and assumptions include valuing equity securities in share-based payment arrangements, estimating the fair value of equity instruments recorded as derivative liabilities, and estimating the useful lives of depreciable assets and whether impairment charges may apply.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
2768000 USD
CY2013Q4 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
3619000 USD
CY2014Q2 nwbo Accrued Expenses Related Party
AccruedExpensesRelatedParty
7000 USD
CY2013Q4 nwbo Accrued Expenses Related Party
AccruedExpensesRelatedParty
5000 USD
CY2014Q2 nwbo Convertible Notes Payable Related Parties Current
ConvertibleNotesPayableRelatedPartiesCurrent
50000 USD
CY2013Q4 nwbo Convertible Notes Payable Related Parties Current
ConvertibleNotesPayableRelatedPartiesCurrent
50000 USD
CY2014Q2 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2013Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
1444788 shares
CY2014Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2013Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1444788 shares
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
40000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
40000000 shares
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28078000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54923000 shares
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29105000 shares
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
57442000 shares
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5100000 USD
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2700000 USD
CY2014Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5101366000 shares
nwbo Lock Up Agreement Description
LockUpAgreementDescription
The Company also entered into a Lock-Up Agreement with Cognate on January 17, 2014, under which Cognate agreed to have all of the shares that are issued as part of the milestone and initiation payments and the invoice conversions under the Cognate Agreements (collectively, the &#8220;Lock-Up Shares&#8221;) locked up for up to 36 months, in return for 15% warrant coverage for each 6-month period of lock-up, on the same terms as the warrants in the Cognate Agreements. During the lock-up, the Lock-Up Shares may not be sold or traded on the market. These lock-up terms are subject to the same most favored nation treatment as provided in the Cognate Agreements as described above.
CY2014Q2 nwbo Warrant Liability
WarrantLiability
31078000 USD
CY2013Q4 nwbo Warrant Liability
WarrantLiability
8688000 USD
CY2014Q1 nwbo Warrant Issued
WarrantIssued
7952000 USD
CY2014Q2 nwbo Warrant Issued
WarrantIssued
2138000 USD
CY2014Q1 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
-16984000 USD
CY2014Q2 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
4684000 USD
CY2014Q1 nwbo Warrant Liability
WarrantLiability
33624000 USD
us-gaap Revenue From Grants
RevenueFromGrants
409000 USD
us-gaap Revenue From Grants
RevenueFromGrants
0 USD
CY2013Q2 us-gaap Revenue From Grants
RevenueFromGrants
272000 USD
CY2014Q2 us-gaap Revenue From Grants
RevenueFromGrants
0 USD
us-gaap Sales Revenue Net
SalesRevenueNet
409000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
0 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
272000 USD
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19991000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41535000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8383000 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21549000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5760000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7570000 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3290000 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3875000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6000 USD
CY2013Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3000 USD
CY2014Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
25757000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
49111000 USD
CY2013Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
11676000 USD
CY2014Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
25427000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-25348000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-49111000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11404000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-25427000 USD
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0 USD
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
10340000 USD
CY2013Q2 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0 USD
CY2014Q2 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
5089000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-12300000 USD
CY2013Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
CY2014Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
4684000 USD
us-gaap Interest Expense
InterestExpense
640000 USD
us-gaap Interest Expense
InterestExpense
155000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
190000 USD
CY2014Q2 us-gaap Interest Expense
InterestExpense
33000 USD
us-gaap Net Income Loss
NetIncomeLoss
-25988000 USD
us-gaap Net Income Loss
NetIncomeLoss
-71906000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-11594000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-25865000 USD
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
6000 USD
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
6000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
482000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
nwbo Accrued Interest Converted To Preferred Stock
AccruedInterestConvertedToPreferredStock
0 USD
nwbo Accrued Interest Converted To Preferred Stock
AccruedInterestConvertedToPreferredStock
76000 USD
nwbo Accreted Interest On Convertible Promissory Note
AccretedInterestOnConvertiblePromissoryNote
61000 USD
nwbo Accreted Interest On Convertible Promissory Note
AccretedInterestOnConvertiblePromissoryNote
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1219000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3087000 USD
CY2014Q2 nwbo Stock Issued During Period Value Conversion Of Accounts Payable To Common Stock And Warrants
StockIssuedDuringPeriodValueConversionOfAccountsPayableToCommonStockAndWarrants
2909000 USD
CY2014Q1 nwbo Stock Issued During Period Value Conversion Of Note Payable And Accrued Interest
StockIssuedDuringPeriodValueConversionOfNotePayableAndAccruedInterest
217000 USD
CY2014Q2 nwbo Convertible Notes Payable Current Related Parties
ConvertibleNotesPayableCurrentRelatedParties
50000 USD
CY2013Q4 nwbo Convertible Notes Payable Current Related Parties
ConvertibleNotesPayableCurrentRelatedParties
75000 USD
CY2014Q2 us-gaap Notes Payable
NotesPayable
1172000 USD
CY2014Q2 nwbo Stock Issued During Period Value Issued For Exchange For Services Non Employees
StockIssuedDuringPeriodValueIssuedForExchangeForServicesNonEmployees
155000 USD
CY2014Q1 nwbo Stock Issued During Period Value Private Placement Net Of Offering Costs
StockIssuedDuringPeriodValuePrivatePlacementNetOfOfferingCosts
224000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.93
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.31
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.40
CY2014Q1 nwbo Stock Issued During Period Value Conversion Of Accounts Payable To Common Stock And Warrants
StockIssuedDuringPeriodValueConversionOfAccountsPayableToCommonStockAndWarrants
5927000 USD
CY2014Q2 nwbo Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
5.32
CY2014Q1 nwbo Number Of Warrants Warrants Exercised For Cash
NumberOfWarrantsWarrantsExercisedForCash
-722 shares
nwbo Number Of Warrants Warrants Exercised For Cash
NumberOfWarrantsWarrantsExercisedForCash
-90 shares
CY2014Q1 nwbo Weighted Average Exercise Pricewarrants Exercised On Cashless Basis
WeightedAverageExercisePricewarrantsExercisedOnCashlessBasis
0
CY2014Q1 nwbo Weighted Average Exercise Price Exercised For Cash
WeightedAverageExercisePriceExercisedForCash
3.66
nwbo Weighted Average Exercise Price Exercised For Cash
WeightedAverageExercisePriceExercisedForCash
4.25
CY2014Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
238496 shares
CY2014Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
24924 shares
CY2014Q1 nwbo Redeemable Shares Number
RedeemableSharesNumber
1444788 shares
CY2014Q1 nwbo Stock Issued During Period Shares Exercise Of Warrant
StockIssuedDuringPeriodSharesExerciseOfWarrant
721827 shares
CY2014Q1 nwbo Stock Issued During Period Value Exercise Of Warrant
StockIssuedDuringPeriodValueExerciseOfWarrant
2700000 USD
CY2014Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1600000 USD
CY2014Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
155607 USD
CY2014Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
2272727 shares
CY2014Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
15000000 USD
CY2013Q4 us-gaap Notes Payable
NotesPayable
1222000 USD
CY2013Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
900000 USD
CY2014Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
100000 USD
CY2013Q1 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
400000 shares
CY2014Q1 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
70000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16497000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27213000 shares
CY2013 us-gaap Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross
ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
3600000 USD
us-gaap Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross
ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
2700000 USD
nwbo One Time Charges Of Service Agreement
OneTimeChargesOfServiceAgreement
4000000 USD
CY2013Q3 nwbo Percentage Of Warrants Coverage
PercentageOfWarrantsCoverage
0.5 pure
CY2013Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
8900000 USD
CY2014Q1 nwbo Potential Redeemable Shares Eligible
PotentialRedeemableSharesEligible
1400000 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
20116 shares
CY2014Q1 nwbo Number Of Warrants Warrants Issued In Exchange For Services
NumberOfWarrantsWarrantsIssuedInExchangeForServices
2434 shares
CY2014Q1 nwbo Class Of Warrant Or Right Issued In Connection With Conversion Of Cognate Accounts Payable
ClassOfWarrantOrRightIssuedInConnectionWithConversionOfCognateAccountsPayable
741 shares
nwbo Class Of Warrant Or Right Issued In Connection With Conversion Of Cognate Accounts Payable
ClassOfWarrantOrRightIssuedInConnectionWithConversionOfCognateAccountsPayable
364 shares
CY2014Q1 nwbo Number Of Warrants Warrants Exercised On Cashless Basis
NumberOfWarrantsWarrantsExercisedOnCashlessBasis
-73 shares
CY2014Q1 nwbo Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
6 shares
CY2013Q4 nwbo Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
5.23
CY2014Q1 nwbo Class Of Warrant Or Right Issued In Exchange Of Services Weighted Average Exercise Price
ClassOfWarrantOrRightIssuedInExchangeOfServicesWeightedAverageExercisePrice
4.00
CY2014Q1 nwbo Class Of Warrant Or Right Issued In Connection With Conversion Of Debt Weighted Average Exercise Price
ClassOfWarrantOrRightIssuedInConnectionWithConversionOfDebtWeightedAverageExercisePrice
4.00
nwbo Class Of Warrant Or Right Issued In Connection With Conversion Of Debt Weighted Average Exercise Price
ClassOfWarrantOrRightIssuedInConnectionWithConversionOfDebtWeightedAverageExercisePrice
4.00
CY2014Q1 nwbo Class Of Warrant Or Right Expired Weighted Average Exercise Price
ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice
9.54
CY2014Q1 nwbo Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
5.12
CY2014Q1 nwbo Stock Issued During Period Value Proceeds From Warrants Exercises
StockIssuedDuringPeriodValueProceedsFromWarrantsExercises
2692000 USD
CY2014Q1 nwbo Cashless Exercises Of Warrants Value
CashlessExercisesOfWarrantsValue
0 USD
CY2014Q2 nwbo Cashless Exercises Of Warrants Value
CashlessExercisesOfWarrantsValue
0 USD
CY2014Q1 nwbo Stock Issued During Period Value Redemption Of Redeemable Securities
StockIssuedDuringPeriodValueRedemptionOfRedeemableSecurities
8913000 USD
CY2014Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 USD
CY2014Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1000 USD
CY2014Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1104000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-46041000 USD
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
-31060000 USD
CY2014Q1 nwbo Class Of Warrant Or Right Issued To Connection With Common Stock Issued
ClassOfWarrantOrRightIssuedToConnectionWithCommonStockIssued
150 shares
nwbo Class Of Warrant Or Right Issued To Connection With Common Stock Issued
ClassOfWarrantOrRightIssuedToConnectionWithCommonStockIssued
281 shares
CY2014Q1 nwbo Class Of Warrant Or Right Issued To Connection With Common Stock Weighted Average Exercise Price
ClassOfWarrantOrRightIssuedToConnectionWithCommonStockWeightedAverageExercisePrice
5.00
nwbo Class Of Warrant Or Right Issued To Connection With Common Stock Weighted Average Exercise Price
ClassOfWarrantOrRightIssuedToConnectionWithCommonStockWeightedAverageExercisePrice
4.00
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
NORTHWEST BIOTHERAPEUTICS INC
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
nwbo Stock And Warrants Issued For Services And Other Expenses
StockAndWarrantsIssuedForServicesAndOtherExpenses
1528000 USD
nwbo Stock And Warrants Issued For Services And Other Expenses
StockAndWarrantsIssuedForServicesAndOtherExpenses
1722000 USD
nwbo Inducement Expenses
InducementExpenses
0 USD
nwbo Inducement Expenses
InducementExpenses
10340000 USD
nwbo Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
251000 USD
nwbo Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
30000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1005000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1385000 USD
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
6638000 USD
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
7986000 USD
nwbo Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
-17000 USD
nwbo Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15283000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27498000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3414000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
400000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
25000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
688000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
nwbo Proceeds From Issuance Of Capital Stock And Warrants
ProceedsFromIssuanceOfCapitalStockAndWarrants
10210000 USD
nwbo Proceeds From Issuance Of Capital Stock And Warrants
ProceedsFromIssuanceOfCapitalStockAndWarrants
2059000 USD
nwbo Repayments Of Offering Costs
RepaymentsOfOfferingCosts
0 USD
nwbo Repayments Of Offering Costs
RepaymentsOfOfferingCosts
1105000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9922000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21266000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5361000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-9646000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7346000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1985000 USD
nwbo Issuance Of Common Stock In Connection Conversion Of Notes Payable
IssuanceOfCommonStockInConnectionConversionOfNotesPayable
1850000 USD
nwbo Issuance Of Common Stock In Connection Conversion Of Notes Payable
IssuanceOfCommonStockInConnectionConversionOfNotesPayable
140000 USD
nwbo Issuance Of Common Stock And Warrants In Connection Conversion Of Accounts Payable
IssuanceOfCommonStockAndWarrantsInConnectionConversionOfAccountsPayable
0 USD
nwbo Issuance Of Common Stock And Warrants In Connection Conversion Of Accounts Payable
IssuanceOfCommonStockAndWarrantsInConnectionConversionOfAccountsPayable
8835000 USD
nwbo Reclass Of Redeemable Security To Equity
ReclassOfRedeemableSecurityToEquity
0 USD
nwbo Reclass Of Redeemable Security To Equity
ReclassOfRedeemableSecurityToEquity
8913000 USD
dei Entity Central Index Key
EntityCentralIndexKey
0001072379
dei Trading Symbol
TradingSymbol
NWBO
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
59504996 shares
CY2014Q2 nwbo Cash In Custody Account
CashInCustodyAccount
3414000 USD
CY2013Q4 nwbo Cash In Custody Account
CashInCustodyAccount
0 USD
nwbo Increase Decrease In Cash In Custody Account
IncreaseDecreaseInCashInCustodyAccount
0 USD
nwbo Increase Decrease In Cash In Custody Account
IncreaseDecreaseInCashInCustodyAccount
-3414000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2014Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2800000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.71
CY2014Q1 nwbo Adjustment To Additional Paid In Capital Inducement Expenses Associated With Conversion Convertible Debt
AdjustmentToAdditionalPaidInCapitalInducementExpensesAssociatedWithConversionConvertibleDebt
2800000 USD
CY2014Q2 nwbo Adjustment To Additional Paid In Capital Inducement Expenses Associated With Conversion Convertible Debt
AdjustmentToAdditionalPaidInCapitalInducementExpensesAssociatedWithConversionConvertibleDebt
1525000 USD
CY2014Q2 nwbo Issuance Of Common Stock Value For Cash And Overallotment Rights
IssuanceOfCommonStockValueForCashAndOverallotmentRights
15000000 USD
CY2014Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
395000 USD
CY2014Q2 nwbo Subscription Receivable For Issuance Of Common Stock Value
SubscriptionReceivableForIssuanceOfCommonStockValue
0 USD
CY2014Q2 nwbo Nonemployee Restricted Sharebased Compensation
NonemployeeRestrictedSharebasedCompensation
2662000 USD
CY2014Q2 nwbo Reclassification Of Equity Instruments Shares
ReclassificationOfEquityInstrumentsShares
200000 shares
CY2014Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
6.60
CY2014Q1 nwbo Proceeds From Shares Payable
ProceedsFromSharesPayable
1400000 USD
CY2014Q2 nwbo Proceeds From Shares Payable
ProceedsFromSharesPayable
1400000 USD
CY2014Q2 nwbo Subscription Receivable For Issuance Of Common Stock Shares
SubscriptionReceivableForIssuanceOfCommonStockShares
16200 shares
CY2014Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
92100 shares
CY2014Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
394925000 USD
CY2014Q2 nwbo Cashless Exercises Of Warrants Shares
CashlessExercisesOfWarrantsShares
12533 shares
CY2014Q2 nwbo Stock Issued During Period Shares Conversion Of Accounts Payable To Common Stock And Warrants
StockIssuedDuringPeriodSharesConversionOfAccountsPayableToCommonStockAndWarrants
727291 shares
CY2014Q1 nwbo Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
3174835 shares
CY2014Q2 nwbo Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
644896 shares
CY2014Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
2460000 USD
CY2014Q2 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
1426000 USD
CY2014Q1 nwbo Stock Issued During Period Value Issued For Services Non Employees
StockIssuedDuringPeriodValueIssuedForServicesNonEmployees
1567000 USD
CY2014Q2 nwbo Working Capital Deficit
WorkingCapitalDeficit
71900000 USD
CY2014Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
125000 USD
CY2013Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
0 USD
nwbo Nonemployee Share Based Compensation
NonemployeeShareBasedCompensation
0 USD
nwbo Nonemployee Share Based Compensation
NonemployeeShareBasedCompensation
10623000 USD
CY2014Q2 nwbo Stock And Warrants Value Issued
StockAndWarrantsValueIssued
2250000 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
2250000 USD
nwbo Proceeds From Issuance Of Common Stock Over Allotment Rights
ProceedsFromIssuanceOfCommonStockOverAllotmentRights
0 USD
nwbo Proceeds From Issuance Of Common Stock Over Allotment Rights
ProceedsFromIssuanceOfCommonStockOverAllotmentRights
15000000 USD
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
2300000 USD
CY2014Q2 nwbo Stock And Warrants Value Issued Under Private Placement
StockAndWarrantsValueIssuedUnderPrivatePlacement
1835000 USD
nwbo Payments For Law Firm Handling Transaction
PaymentsForLawFirmHandlingTransaction
3400000 USD
nwbo Class Of Warrant Or Right Issued In Connection With Registered Direct Offering
ClassOfWarrantOrRightIssuedInConnectionWithRegisteredDirectOffering
2273 shares
nwbo Class Of Warrant Or Right Issued In Connection With Registered Direct Offering Weighted Average Exercise Price
ClassOfWarrantOrRightIssuedInConnectionWithRegisteredDirectOfferingWeightedAverageExercisePrice
7.50
nwbo Class Of Warrant Or Right Issued To Placement Agent In Connection With Registered Direct Offering
ClassOfWarrantOrRightIssuedToPlacementAgentInConnectionWithRegisteredDirectOffering
113 shares
nwbo Class Of Warrant Or Right Issued To Placement Agent In Connection With Registered Direct Offering In Exchange Of Services Weighted Average Exercise Price
ClassOfWarrantOrRightIssuedToPlacementAgentInConnectionWithRegisteredDirectOfferingInExchangeOfServicesWeightedAverageExercisePrice
8.25
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
2300000 USD
CY2014Q1 us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
5101366 shares
nwbo Research And Development Expense Service Agreement
ResearchAndDevelopmentExpenseServiceAgreement
10700000 USD
nwbo Research And Development Expense Service Agreement
ResearchAndDevelopmentExpenseServiceAgreement
28500000 USD

Files In Submission

Name View Source Status
0001144204-14-050484-index-headers.html Edgar Link pending
0001144204-14-050484-index.html Edgar Link pending
0001144204-14-050484.txt Edgar Link pending
0001144204-14-050484-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
nwbo-20140630.xml Edgar Link completed
nwbo-20140630.xsd Edgar Link pending
nwbo-20140630_cal.xml Edgar Link unprocessable
nwbo-20140630_def.xml Edgar Link unprocessable
nwbo-20140630_lab.xml Edgar Link unprocessable
nwbo-20140630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v384947_10q.htm Edgar Link pending
v384947_ex31-1.htm Edgar Link pending
v384947_ex32-1.htm Edgar Link pending